Market Tracker

10/31 10:00pm ET

SciClone Pharmaceuticals Inc (NASDAQ:SCLN)

7.64
Data as of Oct 31
 -0.25 / -3.17%
Today’s Change
4.24
Today|||52-Week Range
8.23
+51.59%
Year-to-Date

Today’s Trading

Previous close7.89
Today’s open8.03
Day’s range7.60 - 8.03
Volume717,377
Average volume (3 months)561,818
Market cap$390.3M
Dividend yield--
Data as of 3:59pm ET, 10/31/2014

Growth & Valuation

Earnings growth (last year)+25.00%
Earnings growth (this year)+145.00%
Earnings growth (next 5 years)+14.70%
Revenue growth (last year)-18.69%
P/E ratio18.2
Price/Sales2.13
Price/Book2.73

Competitors

 Today’s
change
Today’s
% change
PETXAratana Therapeutics...-0.09-0.80%
SCMPSucampo Pharmaceutic...-0.04-0.46%
DERMDermira Inc-0.96-5.88%
PTXPernix Therapeutics ...+0.23+2.42%
Data as of 3:59pm ET, 10/31/2014

Financials

Next reporting dateNovember 10, 2014
EPS forecast (this quarter)$0.12
Annual revenue (last year)$127.1M
Annual profit (last year)$11.0M
Net profit margin8.63%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Friedhelm Blobel
Chief Financial Officer &
Senior Vice President
Wai-Shun Wilson Cheung
Corporate headquarters
Foster City, California

Forecasts